AMIKACIN SULFATE
Generic: AMIKACIN SULFATE
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
AMIKACIN SULFATEActive Substance
1994-04-11Original Approval
AMIKACIN SULFATE is FDA application ANDA063315, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
PYREXIA
166 reports
2
OFF LABEL USE
146 reports
3
DRUG INEFFECTIVE
142 reports
4
NAUSEA
94 reports
5
PNEUMONIA
90 reports
6
SEPSIS
83 reports
7
CONDITION AGGRAVATED
82 reports
8
DYSPNOEA
79 reports
9
DIARRHOEA
76 reports
10
VOMITING
73 reports